These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 36301246)

  • 41. Educational needs and preferred methods of learning among Florida practitioners who order genetic testing for hereditary breast and ovarian cancer.
    Cragun D; Besharat AD; Lewis C; Vadaparampil ST; Pal T
    J Cancer Educ; 2013 Dec; 28(4):690-7. PubMed ID: 23884548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Black and Minority Ethnic women's decision-making for risk reduction strategies after BRCA testing: Use of context and knowledge.
    Machirori M; Patch C; Metcalfe A
    Eur J Med Genet; 2019 May; 62(5):376-384. PubMed ID: 30550831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pregnant Latinas' perspectives on pursuing expanded carrier screening: "It is better to know than not".
    Tedross M; Wang H; Heigl-Maza C; Russell R; Young C; Kramer J; Martinez D; Chen WJ; Robbins-Furman P; Page R; Montalvo-Liendo N; Chen LS
    J Genet Couns; 2023 Aug; 32(4):887-895. PubMed ID: 36949635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
    Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
    JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool.
    Rupert DJ; Squiers LB; Renaud JM; Whitehead NS; Osborn RJ; Furberg RD; Squire CM; Tzeng JP
    Patient Educ Couns; 2013 Aug; 92(2):188-96. PubMed ID: 23664232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exploring United States genetic counselor and healthcare interpreter perspectives: Allocation of roles within the genetic counseling encounter.
    Wang M; Rosenbaum M; Dineen R; Stoll J; Schmitz K; Hsu M
    J Genet Couns; 2022 Aug; 31(4):976-988. PubMed ID: 35416393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative.
    Wood ME; Kadlubek P; Pham TH; Wollins DS; Lu KH; Weitzel JN; Neuss MN; Hughes KS
    J Clin Oncol; 2014 Mar; 32(8):824-9. PubMed ID: 24493722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing.
    Sheppard VB; Mays D; LaVeist T; Tercyak KP
    J Natl Med Assoc; 2013; 105(1):17-22. PubMed ID: 23862292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice.
    Giri VN; Walker A; Gross L; Trabulsi EJ; Lallas CD; Kelly WK; Gomella LG; Fischer C; Loeb S
    Clin Genitourin Cancer; 2022 Apr; 20(2):e104-e113. PubMed ID: 35012874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Communication about genetic testing with breast and ovarian cancer patients: a scoping review.
    Jacobs C; Patch C; Michie S
    Eur J Hum Genet; 2019 Apr; 27(4):511-524. PubMed ID: 30573802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD; Hall MJ
    Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors influencing genetic counseling and testing for hereditary breast and ovarian cancer syndrome in a large US health care system.
    Powell CB; Laurent C; Garcia C; Hoodfar E; Karlea A; Kobelka C; Lee J; Roh J; Kushi LH
    Clin Genet; 2022 Mar; 101(3):324-334. PubMed ID: 34927729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implementing mainstream genetic counseling within the area-wide network of the German Consortium Hereditary Breast and Ovarian Cancer (GC-HBOC): Satisfaction of primary care providers with the provided state-of-the-art training by the Cologne Center.
    Herold N; Bredow K; Ernst C; Tüchler A; Blümcke B; Waha A; Keser E; Hauke J; Wappenschmidt B; Hahnen E; Schmutzler RK; Rhiem K
    J Genet Couns; 2024 Feb; 33(1):206-215. PubMed ID: 38351721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center.
    Chapman-Davis E; Zhou ZN; Fields JC; Frey MK; Jordan B; Sapra KJ; Chatterjee-Paer S; Carlson AD; Holcomb KM
    J Gen Intern Med; 2021 Jan; 36(1):35-42. PubMed ID: 32720237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spanish language concordance in genetic counseling sessions in the United States: Counselor experiences and perceptions of its effects on processes and outcomes.
    de Leon A; McCarthy Veach P; Bro D; LeRoy BS
    J Genet Couns; 2022 Feb; 31(1):188-205. PubMed ID: 34288206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Process evaluation of a culturally targeted video for Latinas at risk of hereditary breast and ovarian cancer.
    Hurtado-de-Mendoza A; Gómez-Trillos S; Graves KD; Carrera P; Campos C; Anderson L; Gronda A; Orellana H; Peshkin BN; Schwartz MD; Cupertino P; Ostrove N; Luta G; Gonzalez N; Sheppard VB
    J Genet Couns; 2021 Jun; 30(3):730-741. PubMed ID: 33222313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Understanding the patient-provider communication needs and experiences of Latina and non-Latina White women following an abnormal mammogram.
    Molina Y; Hohl SD; Ko LK; Rodriguez EA; Thompson B; Beresford SA
    J Cancer Educ; 2014 Dec; 29(4):781-9. PubMed ID: 24748097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.